Chemokine Receptor-4 Targeted PET/CT Imaging with <sup>68</sup>Ga-Pentixafor in Head and Neck Cancer-A Comparison with <sup>18</sup>F-FDG and CXCR4 Immunohistochemistry.

Diagnostics (Basel) · 2024 · PMC11240717 · PMID 39001265

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

There was higher [ 68 Ga]Ga-Pentixafor SUVmax in the HIV-positive patients SUVmax 7.40 ± 3.77 compared with 4.96 (3.48–8.26) in the HIV-negative patients p = 0.323, although this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.